Search Results

240 results for anx

With “1-in-2” Odds AGI Hits by 2030, Here’s What to Do Now

In this issue, I’ll explain the details behind Claude’s new AI agent and how it hints at what we should expect from AGI. Then, I’ll…

Crafting Your Best 2026 Portfolio

We begin each new year with a version of today’s Digest because it’s far more important than any single piece of analysis. None of us…

Hottest Services Stocks Now – ANN ANF HPP LULU

Services stocks finished down 0.2% on Wall Street on Friday.

Hottest Technology Stocks Now – SLH ASX SNX RAX

Technology stocks fell broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 1.0%.

2 Undervalued Big Bank Stocks to Buy

Large bank stocks exceeded forecasts last quarter and could outperform for the balance of 2014. Citigroup (C) and Bank of America (BAC) also feature attractive…

5 College Degrees That Are Great Investments

Find out which college degrees have the highest return on investment compared to university costs and student loan debt

Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?

AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.

Why Greenland, Tariffs, and the Supreme Court Are Colliding

Barrick Gold Set to Shine

Purchasing ABX now and on any pullback could provide substantial reward.

Greenland Headlines Fade… but the Market Risk Doesn’t

In today’s Smart Money, Tom Yeung will share how declining global confidence in the U.S. dollar – driven by geopolitical tensions and a slowing U.S.…

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q1 2024

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Why Financial Advisors Quietly Come to Me to Learn Options

Why Gold’s Rally Can Continue in 2026 and What It Tells Us About the Next Market Shift

In today’s Market 360, I’m going to explain why I believe it can. The reality is that several powerful forces have driven gold’s historic move,…

This Defense Stock Has a 90% Win Rate Starting Feb. 12

A robot autonomously docked with a satellite 22,000 miles above Earth. One firm dominates this tech – and has a 90% win rate Feb. 12-March…

3 Seasonal Stocks to Buy Immediately

Our friends at TradeSmith believe we’re entering some of the best conditions yet for using their Trade Cycles algorithm, and they want you to be…

Ante Into These 7 Gambling Stocks

Although the pandemic took its toll on the gambling industry, these 7 gambling stocks remain a worthy investment for their future growth.

Sell Into Any Rally This Week

We may see a bounce, but the downtrend is still intact.

AnnTaylor Out of Fashion?

AnnTaylor Stores Corp. (ANN) released operating results for the 2008 fiscal year and fourth-quarter ending January 31 that far exceeded the losses expected by analysts.

What New Year’s Resolutions Reveal About Market Timing

CNX Stock Earnings: CNX Resources Beats EPS, Misses Revenue for Q2 2024

CNX stock results show that CNX Resources beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

CNX Stock Earnings: CNX Resources Beats EPS, Misses Revenue for Q1 2024

CNX stock results show that CNX Resources beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Decentraland is Down but Not Out by Any Means

Decentraland is a giant name in the early metaverse. Now that more tech giants are in, consider it as a real opportunity.

5 – 10 of 240 results